← Leaderboards
Matthew D Ringel
Ohio State University
$21,305,885
Attributed
$21,305,885
Total exposure
16
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $6.3M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$55,603,848 · 18
By mechanism
P01$27,628,376 · 5
P50$15,802,508 · 5
R01$7,037,549 · 4
UL1$4,621,413 · 1
P30$259,883 · 2
R21$254,119 · 1
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Albert De La Chapelle$15,372,498
- Sissy M Jhiang$8,729,538
- Andrej Rotter$424,565
Others in their field
Top investigators on “Malignant Neoplasm Of Thyroid”
- David Heimbrook · Leidos Biomedical Research, Inc.$89,819,252
- James A Fagin · Sloan-Kettering Inst Can Research$18,343,965
- Keri Hammel · The Emmes Company, Llc$17,992,237
- Stanley R Hamilton · Johns Hopkins University$17,360,724
- Larry Arthur$15,377,757
- Ignacio I. Wistuba · Ut Southwestern Medical Center$15,303,923
Research focus
Malignant Neoplasm Of ThyroidMalignant NeoplasmsBasePathway InteractionsClinical TrialsTumorUniversitiesIn VivoNeoplasm MetastasisThyroid GlandOhioTumor ProgressionPlaySignal TransductionIn VitroProgramsResearch PersonnelMemberDesignInhibitor/AntagonistCancer CellReportingCancer CenterPapillary Thyroid Carcinoma
Grant awards (85)
Project 01: Cancer Biology (CB)$51,273
P30 · FY2025 · CA · contact PI
RCAN 1.4 metastasis suppressor in thyroid cancer$431,712
R01 · FY2024 · CA · contact PI
Project 01: Cancer Biology (CB)$52,154
P30 · FY2024 · CA · contact PI
RCAN 1.4 metastasis suppressor in thyroid cancer$445,344
R01 · FY2023 · CA · contact PI
Project 01: Cancer Biology (CB)$52,152
P30 · FY2023 · CA · contact PI
The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve Health$4,621,413
UL1 · FY2022 · TR · contact PI
RCAN 1.4 metastasis suppressor in thyroid cancer$443,434
R01 · FY2022 · CA · contact PI
Role of p21-activated kinases in thyroid cancer$367,627
R01 · FY2022 · CA · contact PI
Project 01: Cancer Biology (CB)$52,152
P30 · FY2022 · CA · contact PI
RCAN 1.4 metastasis suppressor in thyroid cancer$460,722
R01 · FY2021 · CA · contact PI
Role of p21-activated kinases in thyroid cancer$375,129
R01 · FY2021 · CA · contact PI
Project 01: Cancer Biology (CB)$52,152
P30 · FY2021 · CA · contact PI
RCAN 1.4 metastasis suppressor in thyroid cancer$452,487
R01 · FY2020 · CA · contact PI
Role of p21-activated kinases in thyroid cancer$375,129
R01 · FY2020 · CA · contact PI
Role of p21-activated kinases in thyroid cancer$363,875
R01 · FY2019 · CA · contact PI
Role of p21-activated kinases in thyroid cancer$388,539
R01 · FY2018 · CA · contact PI
Genetic and Signaling Pathways in Epithelial Thyroid Cancer$2,297,243
P01 · FY2017 · CA · contact PI
The Ohio State University and MD Anderson Cancer Center Thyroid Cancer SPORE$2,278,318
P50 · FY2017 · CA · contact PI
p21 Activated Kinase in Thyroid Cancer$364,204
P01 · FY2017 · CA · contact PI
Developing Combination Therapies for Medullary Thyroid Cancer$301,434
P50 · FY2017 · CA · contact PI
Administrative Core$291,704
P50 · FY2017 · CA · contact PI
Integrated Clinicopathology and Biorespository Core$281,629
P50 · FY2017 · CA · contact PI
Biostatistics Core$149,529
P50 · FY2017 · CA · contact PI
Administrative Core$108,719
P01 · FY2017 · CA · contact PI
Genetic and Signaling Pathways in Epithelial Thyroid Cancer$2,289,198
P01 · FY2016 · CA · contact PI
The Ohio State University and MD Anderson Cancer Center Thyroid Cancer SPORE$2,162,000
P50 · FY2016 · CA · contact PI
p21 Activated Kinase in Thyroid Cancer$393,066
P01 · FY2016 · CA · contact PI
Developing Combination Therapies for Medullary Thyroid Cancer$289,095
P50 · FY2016 · CA · contact PI
Integrated Clinicopathology and Biorespository Core$272,949
P50 · FY2016 · CA · contact PI
Administrative Core$255,131
P50 · FY2016 · CA · contact PI
Biostatistics Core$135,683
P50 · FY2016 · CA · contact PI
Administrative Core$119,208
P01 · FY2016 · CA · contact PI
Genetic and Signaling Pathways in Epithelial Thyroid Cancer$2,268,980
P01 · FY2015 · CA · contact PI
The Ohio State University and MD Anderson Cancer Center Thyroid Cancer SPORE$2,184,999
P50 · FY2015 · CA · contact PI
p21 Activated Kinase in Thyroid Cancer$380,420
P01 · FY2015 · CA · contact PI
RCAN1 in Thyroid Cancer Progression$330,672
R01 · FY2015 · CA · contact PI
Developing Combination Therapies for Medullary Thyroid Cancer$291,102
P50 · FY2015 · CA · contact PI
Integrated Clinicopathology and Biorespository Core$278,842
P50 · FY2015 · CA · contact PI
Administrative Core$261,105
P50 · FY2015 · CA · contact PI
Biostatistics Core$138,027
P50 · FY2015 · CA · contact PI
Administrative Core$120,544
P01 · FY2015 · CA · contact PI
Genetic and Signaling Pathways in Epithelial Thyroid Cancer$2,176,488
P01 · FY2014 · CA · contact PI
The Ohio State University and MD Anderson Cancer Center Thyroid Cancer SPORE$2,162,002
P50 · FY2014 · CA · contact PI
p21 Activated Kinase in Thyroid Cancer$357,853
P01 · FY2014 · CA · contact PI
RCAN1 in Thyroid Cancer Progression$321,307
R01 · FY2014 · CA · contact PI
Developing Combination Therapies for Medullary Thyroid Cancer$285,369
P50 · FY2014 · CA · contact PI
Integrated Clinicopathology and Biorespository Core$277,153
P50 · FY2014 · CA · contact PI
Administrative Core$259,674
P50 · FY2014 · CA · contact PI
Biostatistics Core$141,561
P50 · FY2014 · CA · contact PI
Administrative Core$110,220
P01 · FY2014 · CA · contact PI
Genetic and Signaling Pathways in Epithelial Thyroid Cancer$2,212,542
P01 · FY2013 · CA · contact PI
The Ohio State University and MD Anderson Cancer Center Thyroid Cancer SPORE$2,150,500
P50 · FY2013 · CA · contact PI
p21 Activated Kinase in Thyroid Cancer$364,529
P01 · FY2013 · CA · contact PI
RCAN1 in Thyroid Cancer Progression$313,545
R01 · FY2013 · CA · contact PI
Developing Combination Therapies for Medullary Thyroid Cancer$283,914
P50 · FY2013 · CA · contact PI
Integrated Clinicopathology and Biorespository Core$279,037
P50 · FY2013 · CA · contact PI
Administrative Core$250,910
P50 · FY2013 · CA · contact PI
Biostatistics Core$140,841
P50 · FY2013 · CA · contact PI
Administrative Core$113,674
P01 · FY2013 · CA · contact PI
Genetic and Signaling Pathways in Epithelial Thyroid Cancer$2,209,222
P01 · FY2012 · CA · contact PI
RCAN1 in Thyroid Cancer Progression$335,919
R01 · FY2012 · CA · contact PI
p21 Activated Kinases and EMT in Thyroid Cancer$273,762
P01 · FY2012 · CA · contact PI
Administration and Budgeting$91,205
P01 · FY2012 · CA · contact PI
Genetic and Signaling Pathways in Epithelial Thyroid Cancer$2,247,656
P01 · FY2011 · CA · contact PI
RCAN1 in Thyroid Cancer Progression$350,983
R01 · FY2011 · CA · contact PI
p21 Activated Kinases and EMT in Thyroid Cancer$268,905
P01 · FY2011 · CA · contact PI
Administration and Budgeting$89,590
P01 · FY2011 · CA · contact PI
Genetic and Signaling Pathways in Epithelial Thyroid Cancer$2,460,356
P01 · FY2010 · CA · contact PI
p21 Activated Kinases and EMT in Thyroid Cancer$293,079
P01 · FY2010 · CA · contact PI
Genetic and Signaling Pathways in Epithelial Thyroid Cancer$131,404
P01 · FY2010 · CA · contact PI
Administration and Budgeting$97,651
P01 · FY2010 · CA · contact PI
Genetic and Signaling Pathways in Epithelial Thyroid Cancer$2,398,547
P01 · FY2009 · CA · contact PI
Genetic and Signaling Pathways in Epithelial Thyroid Cancer$409,868
P01 · FY2009 · CA · contact PI
p21 Activated Kinases and EMT in Thyroid Cancer$272,664
P01 · FY2009 · CA · contact PI
Akt Intracellular Localization in Thyroid Cancer$251,966
R01 · FY2009 · CA · contact PI
Administration and Budgeting$90,850
P01 · FY2009 · CA · contact PI
Genetic and Signaling Pathways in Epithelial Thyroid Cancer$2,258,640
P01 · FY2008 · CA · contact PI
p21 Activated Kinases and EMT in Thyroid Cancer$262,873
P01 · FY2008 · CA · contact PI
Akt Intracellular Localization in Thyroid Cancer$251,966
R01 · FY2008 · CA · contact PI
Administration and Budgeting$95,216
P01 · FY2008 · CA · contact PI
Akt Intracellular Localization in Thyroid Cancer$251,966
R01 · FY2007 · CA · contact PI
Akt Intracellular Localization in Thyroid Cancer$259,491
R01 · FY2006 · CA · contact PI
Anti-metastatic Effect of MCIP1 in Thyroid Cancer$125,549
R21 · FY2006 · CA · contact PI
Akt Intracellular Localization in Thyroid Cancer$265,736
R01 · FY2005 · CA
Anti-metastatic Effect of MCIP1 in Thyroid Cancer$128,570
R21 · FY2005 · CA